Senior Scientist for late-stage development, New Product Introduction
Denne stilling er desværre ikke længere ledig.
Se alle ledige stillinger
Bagsværd
Department: NPI Products Location: Bagsværd Are you looking for an opportunity to play a key role in developing new injectable drug products to treat serious chronic diseases? Do you thrive in a high paced environment where you change the way we work, shaping the future of manufacturing at Novo Nordisk? In New Product Introduction (NPI), we are looking for an academic with a can-do-attitude, who is comfortable working with a high level of responsibility to join our team. If you are looking for an opportunity to work with stability and specification of new products and to have an impact on the future of diabetes and obesity products, you might be the person we are looking for in the NPI Stability team. The position As senior scientist you will be allocated a primary drug product, and as drug product responsible you set the stability strategy and participate in ensuring the control strategy. Your responsibilities will include submission as well as questions and answers to authorities. As Senior Scientist in New Product Introduction you will work with late-stage clinical injection products within our areas of diabetes and obesity. You will be involved with several development projects and your responsibilities will include data analysis, documentation, reporting and managing project within our department. You will work in close collaboration with development, Regulatory Affairs and manufacturing sites and you will design, interpret, and report stability studies on drug products. We offer you a creative work environment and your quality conscious and flexible mindset is important in our team as you will be working in a changing environment. Furthermore, the position as senior scientist comes with great possibilities of developing your professional and personal competences. Qualifications We are looking for a colleague who is great with knowledge sharing and thrives in an environment full of interesting challenges. You can see the value in finding solutions by thinking outside the box and challenging the status quo. Preferably, you hold a M.Sc. or PhD within pharmaceutical science, Biotechnology, Biochemistry, Chemistry, Biophysics, or another relevant scientific field. You might have experience working with drug product stability, specifications, and data analysis. You are comfortable with analysing stability data, writing reports (both internal and external) and communicating with stakeholders from several levels in an organisation. You have a strong personal drive that is reflected in your desire to take initiative and have an impact on the business, as well as taking responsibility for your own learning and development. About the department New Product Introduction is a part of Product Supply, in the area Injectable Finished Products (IFP) Manufacturing Development. The department consists of approximately 75 employees split into to 6 teams in Bagsværd. The main responsibility of NPI is bringing products from late-stage development to large scale production. Our team is responsible for product stability studies, regulatory documentation, and transition of development products from development to large scale production. You will be a part of a great team of people with individual competencies that work together to meet deadlines and team goals. Working at Novo Nordisk At Novo Nordisk, we don’t wait for change. We drive it. We’re a dynamic company in an even more dynamic industry, and we know that what got us to where we are today is not necessarily what will make us successful in the future. We embrace the spirit of experimentation, striving for excellence without fixating on perfection. We never shy away from opportunities to develop, we seize them. From research and development, through to manufacturing, marketing, and sales – we’re all working to move the needle on patient care. Contact For further information, please contact Associate Manager Sara Eisenhardt +45 3079 2034 Deadline 18 December 2023
Please note that applications will be assessed on an ongoing basis and therefore the advert may close before the recruitment process is completed if we have proceeded with candidates to the screening or interview phase. We commit to an inclusive recruitment process and equality of opportunity for all our job applicants. At Novo Nordisk we recognize that it is no longer good enough to aspire to be the best company in the world. We need to aspire to be the best company for the world and we know that this is only possible with talented employees with diverse perspectives, backgrounds and cultures. We are therefore committed to creating an inclusive culture that celebrates the diversity of our employees, the patients we serve and communities we operate in. Together, we’re life changing.
Please note that applications will be assessed on an ongoing basis and therefore the advert may close before the recruitment process is completed if we have proceeded with candidates to the screening or interview phase. We commit to an inclusive recruitment process and equality of opportunity for all our job applicants. At Novo Nordisk we recognize that it is no longer good enough to aspire to be the best company in the world. We need to aspire to be the best company for the world and we know that this is only possible with talented employees with diverse perspectives, backgrounds and cultures. We are therefore committed to creating an inclusive culture that celebrates the diversity of our employees, the patients we serve and communities we operate in. Together, we’re life changing.
Information og data
Denne ledige stilling har jobtypen "Øvrige", og befinder sig i kategorien "Øvrige stillinger".
Arbejdsstedet er beliggende i Bagsværd.
Jobbet er oprettet på vores service den 28.11.2023, men kan have været deaktiveret og genaktiveret igen.
Dagligt opdateret: Dette job opdateres dagligt ud fra jobudbyderens hjemmeside via vores søgemaskineteknologi og er aktivt lige nu.
- Øvrige
- Bagsværd
Lignende jobs
-
Senior Associates og Managers til Transaction Advi...
Fri kontaktSenior Associates og Managere til Transaction Advisory Service i København. Vi mærker en stigende efterspørgsel efter rådgivning i forbindelse med køb og salg af virksomheder, herunder finansiel due diligence. Derfor søger vi Senior Associates og Managere til vores TAS team på Østerbro.Få mere info- Øvrige
- København Ø
-
Breakfast Manager, fuldtid, Scandic Webers
Fri kontaktEr du ambitiøs, målrettet og ikke bange for at rydde vanetænkning af bordet, så tror vi på, at du er vores nye Breakfast Manager på Scandic Webers. Vi ved, at du ta’r ansvar og har ro i maven med det fulde overblik. Du er god til at organisere, købe ind, lede og dele din viden.Få mere info- Øvrige
- København
-
Revenue Manager, Scandic Hotel A/S - Support Offic...
Fri kontaktBrænder du for tal, strategi og optimering og har du lyst til at være en del af det danske Revenue Management Team hos Nordens førende hotelkæde? Så tror vi på, at du er vores nye Revenue Manager med interesse for analyse og tal på Scandic Support Office i København.Få mere info- Øvrige
- København
Statistik over udbudte jobs som øvrige i Bagsværd
Herunder ser du udviklingen i udbudte øvrige i Bagsværd over tid. Bemærk at jobs der ikke har en bestemt geografi ikke er medtaget i tabellen. I den første kolonne ser du datoen. I den næste kolonne ser du det samlede antal øvrige.
Se flere statistikker her:
Statistik over udbudte øvrige i Bagsværd over tid
| Dato | Alle jobs som øvrige |
|---|---|
| 26. november 2024 | 71 |
| 25. november 2024 | 70 |
| 24. november 2024 | 76 |
| 23. november 2024 | 76 |
| 22. november 2024 | 70 |
| 21. november 2024 | 65 |
| 20. november 2024 | 66 |
| 19. november 2024 | 65 |
| 18. november 2024 | 64 |
| 17. november 2024 | 73 |
| 16. november 2024 | 73 |
| 15. november 2024 | 70 |
| 14. november 2024 | 69 |
| 13. november 2024 | 66 |
| 12. november 2024 | 62 |
| 11. november 2024 | 60 |
| 10. november 2024 | 62 |
| 9. november 2024 | 62 |
| 8. november 2024 | 59 |
| 7. november 2024 | 58 |
| 6. november 2024 | 57 |
| 5. november 2024 | 57 |
| 4. november 2024 | 53 |
| 3. november 2024 | 58 |
| 2. november 2024 | 57 |
| 1. november 2024 | 56 |
| 31. oktober 2024 | 64 |
| 30. oktober 2024 | 50 |
| 29. oktober 2024 | 49 |
| 28. oktober 2024 | 47 |
| 27. oktober 2024 | 53 |